4//SEC Filing
LA JOLLA PHARMACEUTICAL CO 4
Accession 0000904454-13-001103
CIK 0000920465operating
Filed
Oct 10, 8:00 PM ET
Accepted
Oct 11, 5:16 PM ET
Size
8.7 KB
Accession
0000904454-13-001103
Insider Transaction Report
Form 4
Zarrabian Saiid
Director
Transactions
- Disposition to Issuer
Common Stock
2013-09-24−10,360,892→ 1,480,442 total - Disposition to Issuer
Stock Option (Right to Buy)
2013-09-24−18,907,498→ 0 totalExercise: $0.06Exp: 2022-04-10→ Common Stock (18,907,498 underlying) - Award
Common Stock
2013-09-24+3,981,146→ 5,461,588 total
Footnotes (2)
- [F1]On September 24, 2013, the Issuer cancelled, pursuant to the Restricted Stock Purchase agreement entered into and between the Issuer and the Reporting Person on September 24, 2013, an option for 18,907,498 shares and Restrictcd Stock Units ("RSUs") representing 10,360,892 shares granted to the Reporting Person on April 10, 2012. In exchange for the forfeiture of the option and the RSUs, the Reporting Person received 3,981,146 shares of restricted Common Stock.
- [F2]The cancelled option provided for vesting with respect to one-quarter of the underlying shares on each of April 20, 2012, July 20, 2012, October 20, 2012 and January 20, 2013.
Documents
Issuer
LA JOLLA PHARMACEUTICAL CO
CIK 0000920465
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000920465
Filing Metadata
- Form type
- 4
- Filed
- Oct 10, 8:00 PM ET
- Accepted
- Oct 11, 5:16 PM ET
- Size
- 8.7 KB